Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Post-Discharge Pain Management Following Fractures in Adults in the Emergency Department: The POST-PAIN Study (POST-PAIN)

9 novembre 2026 aggiornato da: Odense University Hospital

Introduction

Every year, about 80,000 adults in Denmark are seen in the emergency department (ED) with a broken bone. Many of these fractures do not need to be set back into place or operated on. Instead, patients are treated with a cast, splint or brace and sent home. At home, patients must manage their pain on their own until seeing a general practitioner or an outpatient clinic, sometimes weeks later. Earlier studies suggest that more than one in three patients still have pain a week after leaving the ED. Little is known about the pain medicine prescribed at discharge, whether patients take it, or whether it works.

Purpose and relevance

The study will describe how pain is managed after discharge. The investigators will examine which pain medicines are prescribed, whether patients follow the treatment plan, how much pain patients experience, and whether side effects occur. The study will also examine how many patients contact a general practitioner, out-of-hours doctor or the ED because of pain within the first week.

This matters for two reasons. Poorly treated pain can reduce quality of life, disturb sleep, slow recovery and lead to additional contact with an already busy health care system. At the same time, strong opioid painkillers (morphine-like medicines) are not clearly better than ordinary painkillers such as paracetamol and ibuprofen for fracture pain. Opioids can cause side effects and carry a risk of dependence, and leftover tablets at home can end up in the hands of others, including young people.

What the study will examine

The main question is how many patients experience moderate to severe pain, defined as 4 or more on a scale from 0 to 10, during the first 24 hours after leaving the ED. The investigators will also examine average pain over seven days, contacts with doctors because of pain, sleep problems caused by pain, side effects, whether patients received a written pain plan, and satisfaction with the pain management plan. In addition, the study will examine how many patients were prescribed opioids and how much unused strong pain medicine remains at home.

Who can take part and how the study works

Adults (18 years or older) with a fracture confirmed in the ED, which does not require reduction or surgery, can be invited to participate. Fractures of the hands and feet are not included, and fractures must be limited to one body region. Patients who cannot provide informed consent, require planned follow-up within two weeks, or have multiple serious injuries cannot participate.

Patients who agree to participate are enrolled at the time of discharge from the ED. For seven days, participants complete a short daily pain diary in a smartphone app or on paper, according to their preference. The diary asks about pain, medicine use, side effects, mood, activity and sleep. One to two weeks after discharge, a member of the research team contacts each participant for a short interview by telephone or video. The interview covers satisfaction with the pain management plan, any contact with doctors because of pain, and any side effects or medicine use not already recorded.

The study is observational, meaning that participants' treatment is not changed as part of the study. The investigators only record what happens during routine care and follow-up. Data will be collected at seven hospitals in Denmark from October 2026 to March 2027. The investigators plan to invite 300 to 400 patients, with approximately 150 expected to complete the full follow-up.

Limitations

Patients are followed for one week only, so the study cannot describe changes in pain or medicine use in the longer term. Most information comes from patient-reported data, which may be less precise than other types of data. Because not all participants are expected to complete the follow-up, the results may not represent all patients.

Clinical importance

The results will provide insight into the pain experienced at home after discharge from the ED. The findings will also show how well current pain management plans work in practice and whether patients receive adequate preparation for managing pain after discharge. In the long term, the findings may form the basis for developing more structured and consistent pain management plans for patients with fractures.

Patient involvement

The patient panel at the ED at Odense University Hospital contributed to the design of the study. Panel members provided feedback on the pain diary, the outcomes and the practical aspects of the study, and reviewed this lay summary. The patient panel will also help prepare the patient information and, if possible, contribute to sharing the results.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Descrizione dettagliata

Background Every year, approximately 80,000 adults in Denmark sustain a fracture. A considerable proportion of these fractures do not require reduction treatment or surgery in the emergency department (ED) and are instead treated with a cast, splint or brace and discharged home. After discharge, patients must manage their pain with limited healthcare support until seeing a general practitioner or an outpatient clinic, often weeks later. Previous studies indicate that 35-37% of patients still experience pain seven days after ED discharge.

Randomized trials in adults with fracture-related pain have not shown a consistent advantage of opioids over non-opioid analgesics such as ibuprofen and paracetamol, and current guidance recommends non-opioids as first-line treatment, with opioids reserved for insufficient effect or severe pain. Nevertheless, opioids continue to be prescribed at discharge, and even short-term exposure carries a risk of dependence and misuse. Leftover opioids at home may also be a source of non-medical use among others, including young adults. Inadequately treated acute pain has been associated with psychological distress, impaired rehabilitation, an increased risk of chronic pain and additional healthcare contacts.

Knowledge about post-discharge pain management after non-reduced fractures is limited, including which analgesics are prescribed, whether patients use them as planned, patient satisfaction, and the frequency of pain-related healthcare contacts. The present study aims to address this knowledge gap. POST-PAIN is conducted by the same multidisciplinary research group as the MIST trial (procedural sedation and analgesia during reduction treatment in the ED), but constitutes an independent study with its own population, objectives and data collection.

Study design POST-PAIN is a prospective, multicenter observational cohort study conducted at seven emergency departments in Denmark. The study involves no intervention and does not change standard care. The study is reported according to the STROBE guidelines. Patient inclusion takes place from October 2026 to March 2027.

Initial treatment assessment The need for reduction treatment or surgery is assessed by the treating ED physician at the time of the ED visit, based on clinical and radiological findings and standard practice at each site. Eligibility is based on this baseline assessment. If the treatment plan changes later (for example, referral to surgery at outpatient follow-up), the patient is not excluded retrospectively, but the change is recorded as a healthcare contact.

Rationale for the study population Fractures of the hand (distal to the wrist) and foot (distal to the ankle) are not included, in order to focus on larger injuries associated with a greater pain burden after discharge.

Procedure Eligible patients are invited to participate in connection with discharge from the ED and receive oral and written information before providing written informed consent. Inclusion is carried out by local site investigators or study staff. The treating physician or nurse is not part of the inclusion staff, in order to limit performance and selection bias. A screening log in REDCap records eligible patients who decline to participate.

For seven days after discharge, participants complete a daily electronic pain diary in the research app MyCap, which sends a reminder at 19:30 each day. If electronic completion is not feasible, a paper diary is offered. A structured follow-up interview is conducted by telephone, or alternatively via Teams, 7-14 days after discharge.

To maximize follow-up, participants receive written information including the study telephone number and are encouraged to save the number in their phone. Participants receive a text message the day before the interview and another on the day of the interview with the approximate time of the call, and can reply to arrange another time. Up to three call attempts are made at different times of the day.

Data collection

Data are collected from three sources and entered into a secure, password-protected REDCap database:

  • Medical records and information provided by the patient at inclusion: Dates of arrival and discharge, fracture location, analgesics prescribed at discharge, whether a written pain management plan was given, pain intensity at discharge, comorbidities and chronic pain conditions, planned follow-up at outpatient clinic, regular use of analgesics or sedatives before the injury, and basic demographic information.
  • The daily pain diary: Average and worst pain intensity on a numerical rating scale (0-10), pain location, analgesic use (type, dose, time and pain before and after intake), adherence to the discharge pain plan, side effects, mood, activity level, sleep (hours, compared to normal, awakenings due to pain) and healthcare contacts due to the injury. The primary outcome is derived from the worst pain intensity reported in the day 1 diary entry.
  • The follow-up interview: Satisfaction with the pain management plan and with the course of care in the ED, pain-related healthcare contacts and reasons, side effects not captured in the diary, planned follow-up at outpatient clinic, prescribed analgesics, self-initiated use of analgesics (including over-the-counter medicine and medicine obtained from relatives), the amount of unused strongly addictive pain medication, and prior analgesic use and comorbidities.

Pain threshold for the primary outcome A pain intensity of 4 or above on the numerical rating scale (0-10) was chosen as the threshold for inadequate pain control, as it corresponds to moderate to severe pain and is consistent with validated cut-off analyses. This threshold ensures clinical relevance of the primary outcome.

Sample size As this is a descriptive study, the sample size is based on the precision of the primary outcome estimate rather than hypothesis testing. Assuming an expected proportion of 45% with inadequate pain control, a two-sided alpha of 0.05 and a desired precision of plus or minus 8 percentage points, 149 patients with complete follow-up are required. Complete follow-up is defined as completion of the pain diary for all seven days and the follow-up interview. To account for an anticipated dropout of up to 50%, approximately 300-400 patients will be invited.

Statistical analysis Continuous variables are presented as mean and standard deviation, or median and interquartile range for non-normally distributed data. Categorical variables are presented as frequencies and percentages with a clearly stated denominator. Missing data are reported descriptively, including the number and proportion per variable and, where relevant, the reason (for example loss to follow-up, incomplete diary, or inability to reach the participant by telephone). A complete-case analysis is used for all outcomes unless otherwise specified, and no imputation of missing data is planned. To assess the risk of selection bias due to loss to follow-up, baseline characteristics (for example age, sex, fracture type, discharge analgesic regimen) and discharge pain intensity are compared descriptively between patients with complete and incomplete follow-up. A biostatistician will be involved in finalizing the statistical analysis plan before data collection starts.

Patient involvement The patient panel at the Emergency Department, Odense University Hospital, contributed to the study design, the selection of outcomes, user-friendliness and feasibility assessment, and reviewed the lay summary. Patients will also contribute to the development of study information materials and, if possible, to the dissemination of the results.

Limitations Inclusion relies on ED staff identifying eligible patients during routine care, so eligible patients may be missed during busy periods. This could introduce selection bias if missed patients differ from those included. After the inclusion period, a registry-based count of the eligible population will be compared with the included cohort on available baseline characteristics to assess representativeness. Follow-up is limited to the first week after discharge, and most data are self-reported.

Data protection All data are handled in accordance with the General Data Protection Regulation. Data are anonymized before publication, and personal data are stored for one year after the end of the project and then destroyed.

Tipo di studio

Osservativo

Iscrizione (Stimato)

300

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Hillerød, Danimarca, 3400
        • Non ancora reclutamento
        • North Zealand Hospital, Hillerød
        • Contatto:
        • Investigatore principale:
          • Jonas A. Andersen
      • Holbæk, Danimarca, 4300
        • Non ancora reclutamento
        • Holbæk Hospital
        • Contatto:
        • Investigatore principale:
          • Jógvan O. Matras
      • Køge, Danimarca, 4600
        • Non ancora reclutamento
        • Zealand University Hospital, Køge
        • Contatto:
        • Investigatore principale:
          • Marie-Laure B. Jacobsson
      • Odense, Danimarca, 5000
        • Reclutamento
        • Odense University Hospital
        • Contatto:
        • Investigatore principale:
          • Jeppe Chr. K. Brendholm
        • Sub-investigatore:
          • Sophie Sværke
      • Slagelse, Danimarca, 4200
        • Non ancora reclutamento
        • Central and West Zealand Hospital, Slagelse
        • Contatto:
        • Investigatore principale:
          • Michael D. Arvig

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Adults (18 years or older) with a fracture confirmed in the emergency department that does not require reduction treatment or surgery, and who are discharged home with conservative treatment (cast, splint or brace). Patients are recruited at discharge from seven emergency departments in Denmark, where they receive oral and written information and give written informed consent.

Descrizione

Inclusion Criteria:

  • Age 18 years or older
  • Fracture confirmed in the emergency department, not requiring reduction treatment or surgical intervention
  • All fracture types except fractures of the hand (distal to the wrist) or foot (distal to the ankle)
  • Fractures limited to one anatomical region: shoulder/upper arm, forearm, hip/femur, lower leg/ankle, pelvis, thorax, spine, or head/face
  • Multiple fractures within the same region are permitted (e.g. fractures of both radius and ulna)

Exclusion Criteria:

  • Unable to give informed consent (e.g. unconscious, psychotic or dementia)
  • Unwilling to participate in the study
  • Prior inclusion in the study
  • Fractures involving more than one anatomical region (e.g. fractures of upper arm and thorax)
  • Multitrauma patients

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Adults With Non-Reduced Fractures Discharged From the Emergency Department

Adults (18 years or older) with a fracture confirmed in the emergency department that does not require reduction treatment or surgery, discharged home with the pain management plan given according to routine care at each site. Participants complete a daily pain diary for 7 days after discharge and a structured follow-up interview by telephone or Teams 7-14 days after discharge. No intervention is assigned.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Proportion of patients with inadequate pain control within 24 hours after discharge
Lasso di tempo: First 24 hours after discharge from the emergency department

Inadequate pain control is defined as a maximum patient-reported pain intensity of 4 or above on the numerical rating scale (0-10, where 0 is no pain and 10 is the worst imaginable pain) during the first 24 hours after discharge. It is derived from the worst pain intensity reported in the day 1 entry of the pain diary.

First 24 hours after discharge from the emergency department

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Mean pain intensity during the 7-day follow-up
Lasso di tempo: 7 days after discharge

Mean of the daily pain intensity reported in the pain diary on the numerical rating scale (0-10).

7 days after discharge
Number of pain-related healthcare contacts
Lasso di tempo: 7 days after discharge

Number of contacts with general practitioners, out-of-hours doctors or the emergency department because of pain, reported in the diary and the follow-up interview.

7 days after discharge
Number of patients with sleep disturbance due to pain
Lasso di tempo: 7 days after discharge

Number of patients reporting awakenings due to pain in the pain diary.

7 days after discharge
Sleep during the follow-up period
Lasso di tempo: Daily for 7 days after discharge

Daily hours of sleep and sleep compared to normal, reported in the pain diary.

Daily for 7 days after discharge
Number of patients discharged with a documented post-discharge pain management plan
Lasso di tempo: Day 0 (at emergency department discharge)

Number and proportion of patients with a documented pain management plan in the patient record at discharge.

Day 0 (at emergency department discharge)
Number and proportion of patients with analgesic side effects
Lasso di tempo: 7 days after discharge (diary) and at the follow-up interview, 7-14 days after discharge

Side effects reported in the pain diary and the follow-up interview.

7 days after discharge (diary) and at the follow-up interview, 7-14 days after discharge
Patient satisfaction with the pain management plan
Lasso di tempo: At the follow-up interview, 7-14 days after discharge

Rated on a 5-point verbal rating scale: not at all, to a small extent, to some extent, to a high extent, to a very high extent.

At the follow-up interview, 7-14 days after discharge
Mean pain intensity during the first 24 hours after discharge
Lasso di tempo: First 24 hours after discharge

Mean pain intensity on the numerical rating scale (0-10) reported in the day 1 pain diary entry.

First 24 hours after discharge

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Number of patients discharged with prescribed opioids
Lasso di tempo: Day 0 (at emergency department discharge)

Number and proportion of patients prescribed an opioid analgesic at discharge from the emergency department, based on the patient record and confirmed at the follow-up interview.

Day 0 (at emergency department discharge)
Analgesic use
Lasso di tempo: 7 days after discharge

Type, dose and timing of analgesics taken, reported in the pain diary.

7 days after discharge
Amount of unused prescribed analgesics with potential for abuse or dependence
Lasso di tempo: At the follow-up interview, 7-14 days after discharge

Amount of strongly addictive pain medication (such as opioids) that was prescribed at discharge but remains unused at follow-up, reported by the patient in the follow-up interview.

At the follow-up interview, 7-14 days after discharge

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

28 ottobre 2026

Completamento primario (Stimato)

22 marzo 2027

Completamento dello studio (Stimato)

31 marzo 2027

Date di iscrizione allo studio

Primo inviato

30 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

9 novembre 2026

Primo Inserito (Effettivo)

12 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • S-20262000 - 152
  • 2026-0845 (Altro numero di sovvenzione/finanziamento: Grosserer L. F. Foghts Fundation)
  • 26/40764 (Altro identificatore: Regional data protection record number)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared. The data contain personal information from patients treated in Danish emergency departments, and participants have not consented to the sharing of their individual data with third parties. Data are handled in accordance with the General Data Protection Regulation, and results will be published in aggregated and anonymized form in a peer-reviewed journal.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .